← BE Semiconductor Industries NV overview

BE Semiconductor Industries NV vs Aehr Test Systems: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

BE Semiconductor Industries NV (BESI.AS)

Q3 2026
▲3▼1

Besi lifts targets and posts record orders on AI hybrid bonding demand

  • Long-term targets raised on AI packaging demand Besi raised its long-term revenue target to €1.7–2.2 billion and lifted the low end of its operating margin goal to 45%, citing stronger hybrid bonding demand for AI data centres and photonics. Higher expected sales and profits support a higher share price.

    This is a new, company-specific upgrade to future growth and profitability that directly lifts the value investors place on Besi.

  • Q2 orders more than double to €292.9 million Second-quarter orders more than doubled from a year earlier to €292.9 million, driven by AI, hybrid bonding, photonics and data centres. The number of customers using its hybrid bonding tools rose to 21 from 15, and management sees momentum continuing into the third quarter.

    Surging orders and wider customer adoption are the clearest evidence that demand for Besi's key AI packaging technology is accelerating.

  • Q2 profit jumps 177% on higher sales and margins Net income surged 177% to €89 million as revenue rose 68.7% to €249.9 million, helped by hybrid bonding, photonics, data centres and mobile demand. The company guided third-quarter revenue 10–15% higher than the second quarter, pointing to continued growth.

    The profit surge and upbeat guidance show the AI-driven demand is already flowing into earnings, which is what ultimately drives the share price.

  • China AI model jitters hit chip equipment shares Besi fell 4.5% as European tech stocks sold off on fears that China's new Kimi K3 AI model rivals top US models, potentially reducing demand for semiconductor equipment. This is a sentiment-driven risk, not a change in Besi's own business.

    It is a real counterweight: a broad, external fear that can pressure Besi's shares even when its own orders and profits are strong.

July 2026
▲3▼1

Besi lifts targets and posts record orders on AI hybrid bonding demand

  • Long-term targets raised on AI packaging demand Besi raised its long-term revenue target to €1.7–2.2 billion and lifted the low end of its operating margin goal to 45%, citing stronger hybrid bonding demand for AI data centres and photonics. Higher expected sales and profits support a higher share price.

    This is a new, company-specific upgrade to future growth and profitability that directly lifts the value investors place on Besi.

  • Q2 orders more than double to €292.9 million Second-quarter orders more than doubled from a year earlier to €292.9 million, driven by AI, hybrid bonding, photonics and data centres. The number of customers using its hybrid bonding tools rose to 21 from 15, and management sees momentum continuing into the third quarter.

    Surging orders and wider customer adoption are the clearest evidence that demand for Besi's key AI packaging technology is accelerating.

  • Q2 profit jumps 177% on higher sales and margins Net income surged 177% to €89 million as revenue rose 68.7% to €249.9 million, helped by hybrid bonding, photonics, data centres and mobile demand. The company guided third-quarter revenue 10–15% higher than the second quarter, pointing to continued growth.

    The profit surge and upbeat guidance show the AI-driven demand is already flowing into earnings, which is what ultimately drives the share price.

  • China AI model jitters hit chip equipment shares Besi fell 4.5% as European tech stocks sold off on fears that China's new Kimi K3 AI model rivals top US models, potentially reducing demand for semiconductor equipment. This is a sentiment-driven risk, not a change in Besi's own business.

    It is a real counterweight: a broad, external fear that can pressure Besi's shares even when its own orders and profits are strong.

Latest
▲3▼1

Besi lifts targets and posts record orders on AI hybrid bonding demand

  • Long-term targets raised on AI packaging demand Besi raised its long-term revenue target to €1.7–2.2 billion and lifted the low end of its operating margin goal to 45%, citing stronger hybrid bonding demand for AI data centres and photonics. Higher expected sales and profits support a higher share price.

    This is a new, company-specific upgrade to future growth and profitability that directly lifts the value investors place on Besi.

  • Q2 orders more than double to €292.9 million Second-quarter orders more than doubled from a year earlier to €292.9 million, driven by AI, hybrid bonding, photonics and data centres. The number of customers using its hybrid bonding tools rose to 21 from 15, and management sees momentum continuing into the third quarter.

    Surging orders and wider customer adoption are the clearest evidence that demand for Besi's key AI packaging technology is accelerating.

  • Q2 profit jumps 177% on higher sales and margins Net income surged 177% to €89 million as revenue rose 68.7% to €249.9 million, helped by hybrid bonding, photonics, data centres and mobile demand. The company guided third-quarter revenue 10–15% higher than the second quarter, pointing to continued growth.

    The profit surge and upbeat guidance show the AI-driven demand is already flowing into earnings, which is what ultimately drives the share price.

  • China AI model jitters hit chip equipment shares Besi fell 4.5% as European tech stocks sold off on fears that China's new Kimi K3 AI model rivals top US models, potentially reducing demand for semiconductor equipment. This is a sentiment-driven risk, not a change in Besi's own business.

    It is a real counterweight: a broad, external fear that can pressure Besi's shares even when its own orders and profits are strong.

Aehr Test Systems (AEHR)

Q3 2026
▲3

Aehr's AI pivot drives record bookings and a bold 2027 revenue forecast

  • Record bookings and AI-driven revenue forecast Aehr reported record quarterly bookings of $60.7 million and guided fiscal 2027 revenue to $130–150 million, nearly triple last year's $50 million. Management says AI processors and silicon photonics are now the main growth drivers, with 71% of revenue from AI-related chips. This directly boosts investor expectations for future sales and profits.

    This is the core new event that explains the stock's surge and future growth outlook.

  • Earnings beat and return to profitability expected Aehr beat earnings estimates with non-GAAP EPS of $0.11 and revenue up 33% year-over-year to $18.8 million. Management expects non-GAAP net income to be 18–22% of revenue in fiscal 2027, signaling a return to profitability. This reassures investors that the company can convert strong demand into actual profits.

    It shows the financial health behind the stock move and supports the bullish case.

  • Successful pivot from EV chips to AI processors Aehr has shifted from relying on electric-vehicle silicon carbide chips to AI accelerators, CPUs, and network processors. Two years ago, over 95% of business was EV-related; now AI chips make up 71% of revenue. This diversification reduces dependence on a single market and taps into the massive AI infrastructure buildout.

    It explains the strategic transformation that is driving new orders and investor enthusiasm.

  • Valuation concerns and analyst caution Despite the strong news, Wall Street sees AEHR as overvalued. The consensus rating is Moderate Buy with a mean price target near $64, implying potential downside of over 40% from recent levels. The stock trades at 81 times trailing sales, so any disappointment could lead to a sharp pullback.

    It provides a fair counterweight to the bullish drivers and highlights the risk for new investors.

July 2026
▲3

Aehr's AI pivot drives record bookings and a bold 2027 revenue forecast

  • Record bookings and AI-driven revenue forecast Aehr reported record quarterly bookings of $60.7 million and guided fiscal 2027 revenue to $130–150 million, nearly triple last year's $50 million. Management says AI processors and silicon photonics are now the main growth drivers, with 71% of revenue from AI-related chips. This directly boosts investor expectations for future sales and profits.

    This is the core new event that explains the stock's surge and future growth outlook.

  • Earnings beat and return to profitability expected Aehr beat earnings estimates with non-GAAP EPS of $0.11 and revenue up 33% year-over-year to $18.8 million. Management expects non-GAAP net income to be 18–22% of revenue in fiscal 2027, signaling a return to profitability. This reassures investors that the company can convert strong demand into actual profits.

    It shows the financial health behind the stock move and supports the bullish case.

  • Successful pivot from EV chips to AI processors Aehr has shifted from relying on electric-vehicle silicon carbide chips to AI accelerators, CPUs, and network processors. Two years ago, over 95% of business was EV-related; now AI chips make up 71% of revenue. This diversification reduces dependence on a single market and taps into the massive AI infrastructure buildout.

    It explains the strategic transformation that is driving new orders and investor enthusiasm.

  • Valuation concerns and analyst caution Despite the strong news, Wall Street sees AEHR as overvalued. The consensus rating is Moderate Buy with a mean price target near $64, implying potential downside of over 40% from recent levels. The stock trades at 81 times trailing sales, so any disappointment could lead to a sharp pullback.

    It provides a fair counterweight to the bullish drivers and highlights the risk for new investors.

Latest
▲3

Aehr's AI pivot drives record bookings and a bold 2027 revenue forecast

  • Record bookings and AI-driven revenue forecast Aehr reported record quarterly bookings of $60.7 million and guided fiscal 2027 revenue to $130–150 million, nearly triple last year's $50 million. Management says AI processors and silicon photonics are now the main growth drivers, with 71% of revenue from AI-related chips. This directly boosts investor expectations for future sales and profits.

    This is the core new event that explains the stock's surge and future growth outlook.

  • Earnings beat and return to profitability expected Aehr beat earnings estimates with non-GAAP EPS of $0.11 and revenue up 33% year-over-year to $18.8 million. Management expects non-GAAP net income to be 18–22% of revenue in fiscal 2027, signaling a return to profitability. This reassures investors that the company can convert strong demand into actual profits.

    It shows the financial health behind the stock move and supports the bullish case.

  • Successful pivot from EV chips to AI processors Aehr has shifted from relying on electric-vehicle silicon carbide chips to AI accelerators, CPUs, and network processors. Two years ago, over 95% of business was EV-related; now AI chips make up 71% of revenue. This diversification reduces dependence on a single market and taps into the massive AI infrastructure buildout.

    It explains the strategic transformation that is driving new orders and investor enthusiasm.

  • Valuation concerns and analyst caution Despite the strong news, Wall Street sees AEHR as overvalued. The consensus rating is Moderate Buy with a mean price target near $64, implying potential downside of over 40% from recent levels. The stock trades at 81 times trailing sales, so any disappointment could lead to a sharp pullback.

    It provides a fair counterweight to the bullish drivers and highlights the risk for new investors.

© 2026 MarketDXWhy